An image report (YM Dawkins et al. Clin Gastroenterol Hepatolo 2016; 14: xxxv-xxxvi) describes a 30-year-old with ulcerative colitis who developed nummular eczema two years after the start of infliximab. He was treated with topical agents and a course of systemic corticosteroids. The authors note that in a few patients, withdrawal of anti-TNF therapy is needed, but this was not needed in their patient.
Related blog posts:
gutsandgrowth 